FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical industry, namely to enzymatic wound healing medication. Enzymatic wound healing medication, which contains enzyme ultra-lysine in form of liquid substance, antiseptic myristamide and auxiliary substances - emuksol-268 and polyethyleneglycol, taken with specified ratio.
EFFECT: medication has increased wound healing activity.
4 dwg, 7 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION FOR TREATMENT OF SUPPURATIVE-NECROTIC WOUNDS (VARIANTS) | 1997 |
|
RU2150936C1 |
BACTERIAL COLLAGENASE-BASE PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2166950C1 |
AGENT FOR TREATMENT OF SUPPURATIVE-NECROTIC PROCESSES | 1998 |
|
RU2145497C1 |
MEDICINAL AGENT SHOWING REGENERATING AND WOUND-HEALING ACTION | 2000 |
|
RU2191574C2 |
METHOD OF TREATING TROPHIC ULCERS AND PERSISTENT SEPTIC WOUNDS | 2013 |
|
RU2545724C1 |
WOUND HEALING PRODUCT IN THE FORM OF AN OINTMENT CONTAINING RUBIDIUM CHLORIDE | 2019 |
|
RU2722127C1 |
AGENT FOR TOPICAL USING IN TREATMENT OF SKIN AND MUCOSA TISSUE DISEASE | 2005 |
|
RU2293557C2 |
OINTMENT FOR TREATMENT OF SUPPURATIVE-INFLAMMATORY DISEASES, BURNS, ARTICULATION INFLAMMATORY DISEASES, TROPHIC ULCERS AND SLUGGISH WOUNDS, METHOD OF ITS PREPARING AND METHOD OF TREATMENT | 1997 |
|
RU2165754C2 |
METHOD FOR REGIONAL TREATMENT OF TROPHIC ULCERS | 2016 |
|
RU2657806C2 |
COMPOSITION ELICITING ANTISEPTIC, REPARATIVE AND ANALGETIC PROPERTIES | 2000 |
|
RU2177314C2 |
Authors
Dates
2013-06-20—Published
2011-08-15—Filed